These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 7872282)
1. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study. Richter JE; Long JF Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282 [TBL] [Abstract][Full Text] [Related]
2. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group. Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446 [TBL] [Abstract][Full Text] [Related]
3. Cisapride compared with ranitidine in the treatment of functional dyspepsia. Carvalhinhos A; Fidalgo P; Freire A; Matos L Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103 [TBL] [Abstract][Full Text] [Related]
4. Cisapride versus ranitidine in the treatment of reflux esophagitis. Janisch HD; Hüttemann W; Bouzo MH Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576 [TBL] [Abstract][Full Text] [Related]
5. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463 [TBL] [Abstract][Full Text] [Related]
6. Cisapride and cimetidine in the treatment of erosive esophagitis. Maleev A; Mendizova A; Popov P; Vlahov V; Dimitrov B; Mihova A; Crowe J; Silveira J; Thomson A; Routhier G Hepatogastroenterology; 1990 Aug; 37(4):403-7. PubMed ID: 2210608 [TBL] [Abstract][Full Text] [Related]
7. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial. McCallum RW; Fink SM; Winnan GR; Avella J; Callachan C Am J Gastroenterol; 1984 Mar; 79(3):165-72. PubMed ID: 6367434 [TBL] [Abstract][Full Text] [Related]
8. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux. Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725 [TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis. Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251 [TBL] [Abstract][Full Text] [Related]
10. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease. Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695 [TBL] [Abstract][Full Text] [Related]
11. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis. Collins BJ; Spence RA; Ferguson R; Laird J; Love AH Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606 [TBL] [Abstract][Full Text] [Related]
12. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial. Sontag S; Robinson M; McCallum RW; Barwick KW; Nardi R Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670 [TBL] [Abstract][Full Text] [Related]
13. The effect of cisapride in patients with reflux esophagitis: an ambulatory esophageal manometry/pH-metry study. Paterson WG; Wang H; Beck IT Am J Gastroenterol; 1997 Feb; 92(2):226-30. PubMed ID: 9040196 [TBL] [Abstract][Full Text] [Related]
14. Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group. Sabesin SM; Berlin RG; Humphries TJ; Bradstreet DC; Walton-Bowen KL; Zaidi S Arch Intern Med; 1991 Dec; 151(12):2394-400. PubMed ID: 1746996 [TBL] [Abstract][Full Text] [Related]
15. [A new granular effervescent 10-mg formulation of cisapride in the treatment of gastroesophageal reflux]. Grossi L; Di Felice F; Marzio L Clin Ter; 1993 Feb; 142(2):127-33. PubMed ID: 8472526 [TBL] [Abstract][Full Text] [Related]
16. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease. Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of hydrotalcite compared with OTC famotidine in the on-demand treatment of gastroesophageal reflux disease: a non-inferiority trial. Konturek JW; Beneke M; Koppermann R; Petersen-Braun M; Weingärtner U Med Sci Monit; 2007 Jan; 13(1):CR44-9. PubMed ID: 17179910 [TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642 [TBL] [Abstract][Full Text] [Related]
19. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis. McKenna CJ; Mills JG; Goodwin C; Wood JR Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]